Cardinal Health, Inc. (CAH) FY2025 Annual P&L / Income Statement

Revenue by Business Segment

2024-07-01 to 2025-06-30

Swipe to see the full flow
Cardinal Health, Inc. (CAH) FY2025 Annual P&L / Income StatementIncome statement for 2024-07-01 through 2025-06-30. View: Business segment. Revenue uses this breakdown; costs and expenses retain the consolidated categories.SOURCESREVENUE RECONCILIATIONREVENUEGROSSOPERATINGPRE-TAXNETPharmaceutical and Specialty SolutionsGMPDOther Operating SegmentRevenueRevenue before reconciliation (calculated)Segment Reporting, Reconciling Item, Corporate NonsegmentGross marginCost of products soldOperating earningsOperating costs, net of other operating items (calculated)Distribution, selling, general, and administrative expensesLitigation (recoveries)/charges, netAcquisition-related cash and share-based compensation costs [Line Items]Restructuring and employee severanceImpairments and (gain)/loss on disposal of assets, netAmortization and other acquisition-related costsEarnings before income taxesOther income (expense), net (calculated)Net earningsIncome Tax Expense (Benefit)Revenue before reconciliation (calculated)Revenue beforereconciliation(calculated)$222.66 BEarnings before income taxesEarnings beforeincome taxes$2.10 BRevenueRevenue$222.58 BGross marginGross margin$8.17 BOperating earningsOperating earnings$2.28 BNet earningsNet earnings$1.57 BOperating costs, net of other operating items (calculated)Operating costs,net (calculated)$5.89 BCost of products soldCost of products sold$214.41 BIncome Tax Expense (Benefit)Income TaxExpense (Benefit)$532.00 MDistribution, selling, general, and administrative expensesDistribution, selling, general,and administrative expenses$5.38 BOther income (expense), net (calculated)Other income,net (calculated)−$174.00 MPharmaceutical and Specialty SolutionsPharmaceutical andSpecialty Solutions$204.64 BLitigation (recoveries)/charges, netLitigation(recoveries)/charges, net−$185.00 MAcquisition-related cash and share-based compensation costs [Line Items]Acquisition-related cash andshare-based compensation costs$126.00 MGMPDGMPD$12.64 BRestructuring and employee severanceRestructuring andemployee severance$88.00 MOther Operating SegmentOther OperatingSegment$5.38 BSegment Reporting, Reconciling Item, Corporate NonsegmentSegment Reporting,Reconciling Item,Corporate Nonsegment−$84.00 MImpairments and (gain)/loss on disposal of assets, netImpairments and (gain)/losson disposal of assets, net$18.00 MAmortization and other acquisition-related costsAmortization and otheracquisition-related costs$464.00 M
Chart details

Cardinal Health, Inc. (CAH) FY2025 Annual P&L / Income Statement

Income statement for 2024-07-01 through 2025-06-30. View: Business segment. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

Revenue
222,578,000,000 US dollars
Cost of products sold
214,410,000,000 US dollars
Gross margin
8,168,000,000 US dollars
Operating costs, net of other operating items (calculated)
5,893,000,000 US dollars
Operating earnings
2,275,000,000 US dollars
Other income (expense), net (calculated)
negative 174,000,000 US dollars
Earnings before income taxes
2,101,000,000 US dollars
Income Tax Expense (Benefit)
532,000,000 US dollars
Net earnings
1,569,000,000 US dollars
GMPD
12,636,000,000 US dollars
Other Operating Segment
5,382,000,000 US dollars
Pharmaceutical and Specialty Solutions
204,644,000,000 US dollars
Distribution, selling, general, and administrative expenses
5,382,000,000 US dollars
Restructuring and employee severance
88,000,000 US dollars
Amortization and other acquisition-related costs
464,000,000 US dollars
Acquisition-related cash and share-based compensation costs [Line Items]
126,000,000 US dollars
Impairments and (gain)/loss on disposal of assets, net
18,000,000 US dollars
Litigation (recoveries)/charges, net
negative 185,000,000 US dollars
Revenue before reconciliation (calculated)
222,662,000,000 US dollars. Sum of the reported revenue categories before the separately reported reconciliation.
Segment Reporting, Reconciling Item, Corporate Nonsegment
negative 84,000,000 US dollars. Reported reconciliation to consolidated revenue.
GMPD costs
12,501,000,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses.
Other Operating Segment costs
4,866,000,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses.
Pharmaceutical and Specialty Solutions costs
202,386,000,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses.
Reconciling items (calculated)
550,000,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses.

Chart connections

  • Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
  • Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.
  • Reported revenue categories plus the separately reported signed reconciliation equals consolidated revenue.
  • Of which attributable to Cardinal Health, Inc.: $1.56 B; to noncontrolling interests: $8.00 M.
Cardinal Health, Inc. (CAH) FY2025 Annual P&L / Income Statement Sankey chart, Business segment view
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Gross margin

3.7%

Gross profit / revenue

Operating margin

1.0%

Operating profit / revenue

Cash conversion

152.8%

Operating cash / net income, same period

Newsletter

Get the teardowns by email

Subscribe if you want the public-company teardowns in your inbox when they're released.

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!